Century Therapeutics, Inc. financial data

Symbol
IPSC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
25 N 38 Th Street, 11 Th Floor, Philadelphia, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.03K % -3.3%
Debt-to-equity 89.5 % +45.1%
Return On Equity -65.4 % -49%
Return On Assets -34.5 % -27.1%
Operating Margin -7.12K % -146%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.7M shares +41.7%
Common Stock, Shares, Outstanding 84.6M shares +42.6%
Common Stock, Value, Issued 8K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 82.1M shares +38.5%
Weighted Average Number of Shares Outstanding, Diluted 82.1M shares +38.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.04M USD -55.3%
General and Administrative Expense 34.6M USD +3.55%
Operating Income (Loss) -145M USD -10%
Nonoperating Income (Expense) 13.8M USD +30.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -132M USD -5.51%
Income Tax Expense (Benefit) -254K USD -111%
Net Income (Loss) Attributable to Parent -131M USD -3.47%
Earnings Per Share, Basic -2.04 USD/shares +5.56%
Earnings Per Share, Diluted -0.38 USD/shares +32.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 41.5M USD -35.7%
Assets, Current 203M USD +26.2%
Property, Plant and Equipment, Net 69.4M USD -17.1%
Operating Lease, Right-of-Use Asset 28.6M USD +14.3%
Intangible Assets, Net (Excluding Goodwill) 33.3M USD
Goodwill 5.09M USD
Assets 416M USD -0.17%
Accounts Payable, Current 3.36M USD -7.37%
Employee-related Liabilities, Current 4.61M USD -6.87%
Liabilities, Current 19.2M USD +0.01%
Deferred Income Tax Liabilities, Net 3.37M USD
Operating Lease, Liability, Noncurrent 52.7M USD +29.1%
Liabilities 194M USD +14.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -309K USD +74.4%
Retained Earnings (Accumulated Deficit) -715M USD -22.5%
Stockholders' Equity Attributable to Parent 222M USD -10.3%
Liabilities and Equity 416M USD -0.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 300M shares +140%
Common Stock, Shares, Issued 84.6M shares +42.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 44.3M USD -33.3%
Operating Lease, Liability 56.4M USD +34.2%
Depreciation 13.6M USD +15.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -130M USD -4.59%
Lessee, Operating Lease, Liability, to be Paid 94.5M USD +8.83%
Property, Plant and Equipment, Gross 98.8M USD -4.64%
Operating Lease, Liability, Current 3.66M USD +210%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.4M USD +21%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.91M USD -39.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +10.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 31.1M USD +5.71%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.96M USD +23.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.2M USD +24.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.5M USD +6.64%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%